Genovior Biotech Corporation operates several aseptic GMP production facilities capable of producing clinical or commercial materials based on CDMO. We have a robust quality assurance procedure and are currently carrying out several CDMO projects about API and injection, which are scheduled to be released in 2022/23. Please contact us to discuss your project requirements. 1. GMP certificate: PIC/S cGMP certificated by Taiwan's FDA 2. One-stop service from Drug Substance (DS/API) to finished product (DP/FDF) 3. CDMO/CMO: Drug Substance/API: HPAPI, Peptide, Protein (E. Coli. & CHO) Drug Product/FDF: Lyo-vial, Liquid-vial, Pre-Filled Syringe (PFS), Cartridge, Pen 4. Field of Manufacture: Oncology/Peptides/Biosimilar/mAb 5. Core technology: Lyophilization/up-&downstream (Fermentation&Purification) 6. Batch size: from pre-clinical trials, clinical trials, commercial trials
